VCEL

57.5201.27%
MH

Michael Halpin

Chief Operating Officer

Mr. Michael Halpin, also known as Mike, has been Chief Operating Officer of Vericel Corporation since June 15, 2019. Mr. Halpin served as Senior Vice President of Quality & Regulatory Affairs at Vericel Corporation since April 10, 2017 until June 15, 2019. Mr. Halpin formerly served as vice president, North American region regulatory head at Sanofi Genzyme, with responsibility for Sanofi Genzyme's rare disease, immuno-inflammatory, multiple sclerosis and other business unit products. Previously, Mr. Halpin served as vice president, regulatory affairs for Genzyme's biosurgery division, with regulatory oversight of all biosurgery and cell and gene therapy products, including Carticel®, Epicel®, and MACI®. Prior to Genzyme, he held a number of regulatory, quality and clinical affairs positions at several medical device companies, including Abbott/MediSense, C.R. Bard and Abiomed. Mr. Halpin received his master's degree in biomedical engineering and bachelor's degree in biochemistry from the University of Virginia.

Positions